tradingkey.logo

Intuitive Surgical Inc

ISRG
503.950USD
-3.600-0.71%
Fechamento 01/30, 16:00ETCotações atrasadas em 15 min
178.65BValor de mercado
62.98P/L TTM

Intuitive Surgical Inc

503.950
-3.600-0.71%

Mais detalhes de Intuitive Surgical Inc Empresa

Intuitive Surgical, Inc. develops, manufactures, and markets da Vinci surgical systems and the Ion endoluminal system. The Company specializes in invasive care and robotic-assisted surgery. Its technologies include the da Vinci surgical systems and the Ion endoluminal system. The da Vinci surgical system is designed to enable surgeons to perform a range of surgical procedures within its targeted general surgery, urologic, gynecologic, cardiothoracic, and head and neck specialties and consists of a surgeon's console or consoles, a patient-side cart, and a high-performance vision system. The Ion endoluminal system is a flexible, robotic-assisted, catheter-based platform for which the cleared indication is minimally invasive biopsies in the lung and consists of a system cart, a controller, a catheter, and a vision probe. Its Ion system extends its commercial offering beyond surgery into diagnostic and endoluminal procedures.

Informações de Intuitive Surgical Inc

Código da empresaISRG
Nome da EmpresaIntuitive Surgical Inc
Data de listagemJun 13, 2000
CEORosa (David J)
Número de funcionários15638
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 13
Endereço1020 Kifer Road
CidadeSUNNYVALE
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal94086
Telefone14085232100
Sitehttps://www.intuitive.com/en-us/about-us/company
Código da empresaISRG
Data de listagemJun 13, 2000
CEORosa (David J)

Executivos da empresa Intuitive Surgical Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%
Dr. Monica P. Reed, M.D.
Dr. Monica P. Reed, M.D.
Independent Director
Independent Director
2.35K
+739.00%
Ms. Sreelakshmi Kolli
Ms. Sreelakshmi Kolli
Independent Director
Independent Director
979.00
+739.00%
Mr. Mark Preston Brosius
Mr. Mark Preston Brosius
Senior Vice President, Chief Manufacturing and Supply Chain Officer
Senior Vice President, Chief Manufacturing and Supply Chain Officer
852.00
-1076.00%
Mr. Lewis Chew
Mr. Lewis Chew
Independent Director
Independent Director
783.00
+739.00%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Gary S. Guthart, Ph.D.
Dr. Gary S. Guthart, Ph.D.
Executive Chairman of the Board
Executive Chairman of the Board
1.29M
+1000.00%
Mr. David J. Rosa
Mr. David J. Rosa
Chief Executive Officer, Director
Chief Executive Officer, Director
228.75K
-5454.00%
Dr. Craig H. Barratt, Ph.D.
Dr. Craig H. Barratt, Ph.D.
Lead Independent Director
Lead Independent Director
26.16K
--
Ms. Amal M. Johnson
Ms. Amal M. Johnson
Independent Director
Independent Director
13.01K
+739.00%
Mr. Joseph C. Beery
Mr. Joseph C. Beery
Independent Director
Independent Director
3.11K
+739.00%
Mr. Henry L. Charlton
Mr. Henry L. Charlton
Executive Vice President, Chief Commercial and Marketing Officer
Executive Vice President, Chief Commercial and Marketing Officer
3.00K
-4731.00%

Detalhamento da receita

Moeda: USDAtualizado em: ter, 6 de jan
Moeda: USDAtualizado em: ter, 6 de jan
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%
Por RegiãoUSD
Nome
Receita
Proporção
U.S.
1.72B
68.56%
Outside of United states
787.50M
31.44%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Instruments and accessories
1.52B
60.63%
Systems
590.40M
23.57%
Services
395.90M
15.80%

Distribuição de ações

Atualizado em: dom, 16 de nov
Atualizado em: dom, 16 de nov
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
Outro
75.05%
Investidores
Investidores
Proporção
The Vanguard Group, Inc.
9.43%
BlackRock Institutional Trust Company, N.A.
5.33%
State Street Investment Management (US)
4.38%
T. Rowe Price Associates, Inc.
3.46%
Geode Capital Management, L.L.C.
2.33%
Outro
75.05%
Tipos de investidores
Investidores
Proporção
Investment Advisor
49.26%
Investment Advisor/Hedge Fund
27.06%
Hedge Fund
3.07%
Research Firm
2.90%
Pension Fund
2.47%
Bank and Trust
2.40%
Sovereign Wealth Fund
1.44%
Individual Investor
0.51%
Family Office
0.32%
Outro
10.58%

Participação acionária institucional

Atualizado em: qui, 1 de jan
Atualizado em: qui, 1 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q4
3647
313.93M
88.55%
-8.96M
2025Q3
3649
310.67M
87.63%
-11.36M
2025Q2
3621
320.38M
89.37%
-5.49M
2025Q1
3598
321.67M
89.74%
-4.21M
2024Q4
3426
322.11M
90.31%
-1.17M
2024Q3
3255
319.27M
89.84%
-8.25M
2024Q2
3152
322.86M
91.02%
+572.17K
2024Q1
3116
317.58M
89.60%
-829.16K
2023Q4
3055
314.33M
89.27%
-2.70M
2023Q3
2961
312.82M
89.02%
-3.61M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
33.43M
9.43%
+258.72K
+0.78%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
18.90M
5.33%
-196.41K
-1.03%
Sep 30, 2025
State Street Investment Management (US)
15.54M
4.38%
-12.88K
-0.08%
Sep 30, 2025
T. Rowe Price Associates, Inc.
12.28M
3.46%
-605.75K
-4.70%
Sep 30, 2025
Geode Capital Management, L.L.C.
8.27M
2.33%
+84.99K
+1.04%
Sep 30, 2025
Invesco Capital Management (QQQ Trust)
7.95M
2.24%
+438.98K
+5.84%
Dec 31, 2025
Capital World Investors
7.73M
2.18%
+116.03K
+1.52%
Sep 30, 2025
Fidelity Management & Research Company LLC
4.84M
1.36%
-3.59M
-42.62%
Sep 30, 2025
Norges Bank Investment Management (NBIM)
4.73M
1.33%
+127.12K
+2.76%
Jun 30, 2025
AllianceBernstein L.P.
4.04M
1.14%
-153.40K
-3.66%
Sep 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 2 de out
Atualizado em: qui, 2 de out
Nome
Proporção
Langar Global HealthTech ETF
14.08%
iShares U.S. Medical Devices ETF
13.62%
Simplify Health Care ETF
6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
6.58%
Global X Robotics & Artificial Intelligence ETF
6.53%
Invesco AI and Next Gen Software ETF
5%
Goldman Sachs Future Health Care Equity ETF
4.73%
iShares US Select Equity Active ETF
4.67%
Neuberger Berman Disrupters ETF
4.34%
Fidelity Digital Health ETF
3.66%
Ver Mais
Langar Global HealthTech ETF
Proporção14.08%
iShares U.S. Medical Devices ETF
Proporção13.62%
Simplify Health Care ETF
Proporção6.65%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporção6.58%
Global X Robotics & Artificial Intelligence ETF
Proporção6.53%
Invesco AI and Next Gen Software ETF
Proporção5%
Goldman Sachs Future Health Care Equity ETF
Proporção4.73%
iShares US Select Equity Active ETF
Proporção4.67%
Neuberger Berman Disrupters ETF
Proporção4.34%
Fidelity Digital Health ETF
Proporção3.66%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Data ex-dividendo
Tipo
Proporção
Aug 05, 2021
Split
1→3
Data
Data ex-dividendo
Tipo
Proporção
Aug 05, 2021
Split
1→3
KeyAI